BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 22484618)

  • 1. Differentiation and enrichment of cardiomyocytes from human pluripotent stem cells.
    Xu C
    J Mol Cell Cardiol; 2012 Jun; 52(6):1203-12. PubMed ID: 22484618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery.
    Braam SR; Passier R; Mummery CL
    Trends Pharmacol Sci; 2009 Oct; 30(10):536-45. PubMed ID: 19762090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiomyocytes derived from human embryonic stem cells - characteristics and utility for drug discovery.
    Steel D; Hyllner J; Sartipy P
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):133-40. PubMed ID: 19152222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models.
    Freund C; Mummery CL
    J Cell Biochem; 2009 Jul; 107(4):592-9. PubMed ID: 19449339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiomyocytes derived from pluripotent stem cells: progress and prospects from China.
    Yang HT; Zhang M; Huang J; Liang H; Zhang P; Boheler KR
    Exp Cell Res; 2013 Jan; 319(2):120-5. PubMed ID: 23022397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspective from the heart: the potential of human pluripotent stem cell-derived cardiomyocytes.
    Xu XQ; Sun W
    J Cell Biochem; 2013 Jan; 114(1):39-46. PubMed ID: 22903726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pluripotent stem cell models of cardiac disease and their implication for drug discovery and development.
    Davis RP; van den Berg CW; Casini S; Braam SR; Mummery CL
    Trends Mol Med; 2011 Sep; 17(9):475-84. PubMed ID: 21703926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of 'stemness' and stem cell differentiation by microRNAs.
    Sartipy P; Olsson B; Hyllner J; Synnergren J
    IDrugs; 2009 Aug; 12(8):492-6. PubMed ID: 19629883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impacts of recent advances in cardiovascular regenerative medicine on clinical therapies and drug discovery.
    Murata M; Tohyama S; Fukuda K
    Pharmacol Ther; 2010 May; 126(2):109-18. PubMed ID: 20156482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiomyocyte differentiation of human induced pluripotent stem cells.
    Zwi L; Caspi O; Arbel G; Huber I; Gepstein A; Park IH; Gepstein L
    Circulation; 2009 Oct; 120(15):1513-23. PubMed ID: 19786631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Directed differentiation of pluripotent stem cells: from developmental biology to therapeutic applications.
    Irion S; Nostro MC; Kattman SJ; Keller GM
    Cold Spring Harb Symp Quant Biol; 2008; 73():101-10. PubMed ID: 19329573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiomyocyte differentiation of pluripotent stem cells and their use as cardiac disease models.
    Dambrot C; Passier R; Atsma D; Mummery CL
    Biochem J; 2011 Feb; 434(1):25-35. PubMed ID: 21269276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human embryonic stem cells for cardiomyogenesis.
    Habib M; Caspi O; Gepstein L
    J Mol Cell Cardiol; 2008 Oct; 45(4):462-74. PubMed ID: 18775434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient differentiation of cardiomyocytes from human pluripotent stem cells with growth factors.
    Jha R; Xu RH; Xu C
    Methods Mol Biol; 2015; 1299():115-31. PubMed ID: 25836579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiomyocytes derived from human pluripotent stem cells for drug screening.
    Zeevi-Levin N; Itskovitz-Eldor J; Binah O
    Pharmacol Ther; 2012 May; 134(2):180-8. PubMed ID: 22269465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons from the heart: mirroring electrophysiological characteristics during cardiac development to in vitro differentiation of stem cell derived cardiomyocytes.
    van den Heuvel NH; van Veen TA; Lim B; Jonsson MK
    J Mol Cell Cardiol; 2014 Feb; 67():12-25. PubMed ID: 24370890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of cardiomyocytes from new human embryonic stem cell lines derived from poor-quality blastocysts.
    Raya A; Rodríguez-Pizà I; Arán B; Consiglio A; Barri PN; Veiga A; Izpisúa Belmonte JC
    Cold Spring Harb Symp Quant Biol; 2008; 73():127-35. PubMed ID: 19028986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocols for cardiac differentiation of embryonic stem cells.
    Pucéat M
    Methods; 2008 Jun; 45(2):168-71. PubMed ID: 18593613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes.
    Hemmi N; Tohyama S; Nakajima K; Kanazawa H; Suzuki T; Hattori F; Seki T; Kishino Y; Hirano A; Okada M; Tabei R; Ohno R; Fujita C; Haruna T; Yuasa S; Sano M; Fujita J; Fukuda K
    Stem Cells Transl Med; 2014 Dec; 3(12):1473-83. PubMed ID: 25355733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological response of human cardiomyocytes derived from virus-free induced pluripotent stem cells.
    Mehta A; Chung YY; Ng A; Iskandar F; Atan S; Wei H; Dusting G; Sun W; Wong P; Shim W
    Cardiovasc Res; 2011 Sep; 91(4):577-86. PubMed ID: 21565833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.